Surgical volume, ancillary margin, and a wait list that hides both.
Orthopedic practices carry several businesses at once: clinic, imaging, therapy, and surgery, often across more than one site of service. Total revenue can rise while the profitable lines shrink. The monthly briefing separates those lines, reads conversion from clinic to surgery, and tracks the authorization and collection behavior that decides how much of the work turns into cash.
Where the specialty stands
Orthopedics has migrated meaningfully outpatient: total joints in ASCs are now standard, spine is following, and bundled payments continue to reshape episode economics. Implant cost capture, robotics utilization, and physical-therapy referral leakage are the levers that separate well-run groups from the rest.
- CMS site-neutral and ASC migration policies keep shifting more cases out of HOPDs; ASC ownership is the strategic question.
- Robotics adoption (Mako, ROSA, Velys) is broad but utilization quality is uneven; revenue-per-case and turnover time are the right metrics.
- Bundled payment and direct-to-employer arrangements reward groups that own the full episode from imaging through PT.
- Implant pricing, distributor consolidation, and supply chain tactics are an underrated margin lever.
- Workforce: OR techs and surgical RN supply remain the binding constraint on case volume in many markets.
What the briefing reads for a orthopedics practice
New patient volume, surgical conversion rate, and time from decision to case date. A long backlog looks like demand strength and often hides lost cases.
Imaging, physical therapy, DME, and injections read on their own margins. These lines are sensitive to payer policy and to referral discipline inside the practice.
ASC versus hospital outpatient versus inpatient, including any ownership interest. Case migration changes practice income even when surgical volume is flat.
Approval turnaround and denial reasons by payer, especially for imaging, injections, and higher-cost procedures. Delay here becomes a scheduling problem before it becomes a cash problem.
Work effort, case mix, and clinic days per surgeon against compensation. Mix shifts between surgical and nonsurgical work change the economics of the same schedule.
Support staff per provider, cast and therapy staffing, and cost per visit against volume growth.
Illustrative reference ranges
Read the methodologyThese internally authored, industry-informed estimates provide specialty context. They are not live peer data, licensed survey medians, targets, or promises.
| Indicator | Lower reference | Central reference | Upper reference |
|---|---|---|---|
| Revenue per provider (monthly) | $75k | $95k | $115k |
| Days in A/R | 32 days | 40 days | 48 days |
| No-show rate | 6% | 9% | 12% |
| Operating expense ratio | 58% | 64% | 70% |
| Average reimbursement rate | 64% | 72% | 80% |
| Scheduling efficiency | 70% | 78% | 86% |
| Net collection rate | 93% | 95.8% | 97.6% |
| Contractual adjustment rate | 28% | 34% | 40% |
| Commercial payer mix | 55% | 68% | 80% |
| Third next available appointment | 8 days | 14 days | 20 days |
| Staff per provider | 2.6 | 3.2 | 3.8 |
| Provider turnover | 4% | 7% | 11% |
| Training investment (% of payroll) | 1% | 1.8% | 2.6% |
| Cost per visit | $200 | $240 | $290 |
| Patient satisfaction | 4.1 / 5 | 4.4 / 5 | 4.6 / 5 |
| Quality compliance rate | 86% | 91% | 95% |
Questions this briefing is built to answer
- How many surgical candidates do we lose between consult and case date?
- What is imaging actually contributing after equipment, staffing, and denials?
- Where is our case volume going, and what does that do to practice income?
- Which payers are driving authorization delays this quarter?
- Is compensation aligned with the work each surgeon is actually producing?
- Is overhead growing faster than surgical and clinic volume?
What we read to stay current
See what this looks like for your practice
Send aggregate practice data for a recent period and we will show you the executive brief format: what changed, why it may matter, likely drivers, and what to watch.
AileronMD analyzes business, financial, and operational data only. Do not submit patient records or protected health information. AileronMD does not provide clinical or medical advice, and does not guarantee financial results. Guidance is advisory; practice leadership makes the decisions.